- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03509909
Yoga and Physical Activity for Veterans
Mechanisms of Change in Yoga and Physical Activity for Veterans
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Posttraumatic stress disorder (PTSD) is a chronic, debilitating condition with a broad negative impact on physical and mental health functioning. Excellent, empirically-supported interventions for PTSD are readily available to Veterans, but the majority of patients who receive the best available treatments continue to have a diagnosable disorder after treatment. This suggests that complementary interventions may be useful to fully restore functioning. In addition, many patients seek alternatives to psychotherapy or pharmacotherapy. This is evident in the increasing numbers of individuals with PTSD are turning to alternative approaches. At present, however, the investigators lack a good evidence base from which to make recommendations about the use of complementary and alternative approaches.
Yoga is very popular practice, touted to enhance physical, mental and spiritual well-being. Many Veterans with PTSD have turned to yoga as a part of their recovery plan, often seeking care outside the specialty mental health system. Initial evidence suggests that the practice leads to clinically significant change in symptoms, but results are yet inconclusive, particularly in Veterans. Thus, this project will provide additional data as to efficacy of yoga for Veterans PTSD.
The study is a randomized controlled trial involving approximately 100 Veterans with PTSD from the San Diego area. These Veterans will be randomized to receive a manualized hatha yoga intervention or a supportive exercise control condition. Both interventions will be delivered by trained instructors via livestreaming or recorded classes over a 12-week period. Assessment of clinical outcomes and methodological variables will take place before, during, immediately after, and 3-months after the intervention. Analyses will focus on change in the intervention groups over time and the degree to which change is associated with the candidate mechanisms.
Results of this study have the potential to inform the way in which yoga is delivered to Veterans as well as to increase knowledge about the underlying processes by which PTSD can be ameliorated. Given the high demand for yoga demand by individuals with PTSD and the degree to which the practice is already being provided in many clinical settings, findings from this study will be immediately relevant. Findings may also guide future research in complementary and alternative approaches by demonstrating the principle of targeting different processes of change to create an integrative care plan.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92161-0002
- VA San Diego Healthcare System, San Diego, CA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veterans who have clinically meaningful PTSD symptoms
Exclusion Criteria:
- serious suicidality or homicidality that has required urgent or emergent evaluation or treatment within the past three months
a known, untreated substance abuse or dependence problem
- inclusion is possible if there is evidence that the individual has been afforded and is complying with treatment for the substance problem
- serious mental disorders, such as psychotic disorders or bipolar type I, or serious dissociative symptoms
- cognitive impairment that would interfere with treatment
circumstances that lead to recurrent traumatization
- e.g., engaged in a violent relationship
- any medical condition for which exercise is contraindicated, including pregnancy
concurrent enrollment in any other treatment specifically targeting PTSD symptoms or in any meditative or mind-body intervention
- including yoga practice >1 class/month in the preceding 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hatha yoga
12- week group-based yoga class
|
Manualized hatha yoga
|
|
Active Comparator: Supportive exercise
12-week group-based stretching and strengthening class
|
Manualized stretching and strengthening
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinician Administered PTSD Scale for Diagnostic and Statistical Manual Version 5 (CAPS-5)
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Semi-structured clinical interview assessing severity of PTSD symptoms administered by a trained, blinded assessor.
The range of scores is 0-80.
Mpre-Mpost is presented, so positive numbers indicate a reduction in PTSD symptom severity from before to after the intervention.
|
Baseline to post-treatment (approx 12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire Depression Items (PHQ-9)
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Self-report measure of depressive symptoms with a range of 0-27.
Mpre-Mpost is presented, so positive numbers indicate a reduction in depression severity.
|
Baseline to post-treatment (approx 12 weeks)
|
|
State-Trait Anxiety Inventory, State Subscale
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Self-report measure of anxiety symptoms with "state" and "trait" subscales; state is reported.
The subscale scores range from 20 to 80. Mpre-Mpost is presented, so positive numbers indicate a reduction in anxiety.
|
Baseline to post-treatment (approx 12 weeks)
|
|
State-Trait Anger Expression Inventory - II (STAXI-II), State Anger Subscale
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Self-report measure of anger with three major subscales (state anger, trait anger and anger control index), which are quantified as T-scores (i.e., 50 indicates the population mean with a standard deviation of 10), calculated from published adult norms tables.
Change in T-scores, Tpre-Tpost, is presented, so positive numbers indicate a reduction in anger.
|
Baseline to post-treatment (approx 12 weeks)
|
|
Insomnia Severity Index
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Self-report measure of insomnia with a range of 0-28.
Mpre-Mpost is presented, so positive numbers indicate a reduction in sleep disturbance.
|
Baseline to post-treatment (approx 12 weeks)
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 4a
Time Frame: Baseline to post-treatment (approx 12 weeks)
|
Self-report measure of pain interference, reported as a T-score (i.e., 50 indicates the population mean with a standard deviation of 10) calculated from published adult norms table.
Change in T-scores, Tpre-Tpost, is presented, so positive numbers indicate a reduction in pain interference.
|
Baseline to post-treatment (approx 12 weeks)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ariel J. Lang, PhD, VA San Diego Healthcare System, San Diego, CA
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MHBB-007-17F
- CX001647-01A1 (Other Grant/Funding Number: VA CSR&D)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
COMPASS PathwaysNot yet recruitingPTSD | PTSD, Post Traumatic Stress Disorder | PTSD Symptoms | PTSD - Post Traumatic Stress Disorder
-
Valhalla Project NiagaraRecruiting
-
York UniversityRecruiting
-
VA Office of Research and DevelopmentCompleted
-
Tonix Pharmaceuticals, Inc.Withdrawn
-
University of Wisconsin, MadisonCompleted
-
University of PennsylvaniaUniversity of TexasCompleted
-
Johns Hopkins UniversitySchool of Biomedical Sciences, University of Otago, Dunedin, New Zealand; D...Completed
Clinical Trials on Hatha yoga
-
University of MinnesotaThe John A. Hartford Foundation; St. Catherine University; Midwest Nursing Center...CompletedQuality of Life | Osteoarthritis, Knee | Poor Quality Sleep | Physical ImpairmentUnited States
-
University of MinnesotaCompleted
-
University of Texas at AustinCompleted
-
Universität Duisburg-EssenCompleted
-
Massachusetts General HospitalBrown UniversityCompletedDepression | Mood Disorders | Bipolar DisorderUnited States
-
Rob RutledgeNova Scotia Health Authority; Dalhousie University; IWK Health CentreCompleted
-
Southern Methodist UniversityCompletedDepression | Anxiety | Psychological Distress | Physiological StressUnited States
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
Angus YuThe Hong Kong Jockey Club Charities TrustCompleted